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Immunocytochemical methods were used to study protein kinase C (PKC) distribution in HL60 cells during the entire 
course of 12-0-tetradecanoylphorbol-13-acetate (TPA)-induced differentiation. After an initial translocation of PKC 
from cytoplasm to plasma membrane, the enzyme was localized close to the nuclear membrane region at day 1 of TPA 
treatment. PKC was associated with nuclei at day 2 and with nuclei, cytoplasm and plasma membrane at days 3 and 
5. Attachment of cells to substratum (day 2) was accompanied by increased phosphorylation of several nuclear proteins. 
At day 7, the differentiated cells became detached and PKC in these cells was largely cytoplasmic. In view of the crucial 
role of PKC in cell differentiation, it is expected that changes in its intracellular localization have physiological 
significance. 
Differentiation; 12-0-tetradecanoylphorbol-13-acetate; Protein kinase C 
1. INTRODUCTION 
Tumor promoting TPA induces macrophage- 
type differentiation of human promyelocytic 
leukemia HL60 cells [ 1,2]. The primary target of 
TPA action is PKC [3] which occurs widely in 
animal cells [4]. Data obtained with the use of 
TPA-resistant cell lines [5-71 and various PKC in- 
hibitors [8-l l] suggest that PKC has a crucial role 
in the regulation of leukemic cell differentiation. 
The biochemical changes which trigger differentia- 
tion are still largely unknown. However, both 
topoisomerase II [12] and polymerase II [13] have 
been shown to serve as substrates for PKC, in- 
dicating that some nuclear functions are potential- 
IY regulated by this kinase. Increased 
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phosphatidylcholine (PC) metabolism in the 
plasma membrane has also been shown to be an 
important marker of differentiating HL60 cells 
[14]. All these suggest that phosphorylation of 
both plasma membrane and nuclear proteins by a 
TPA-stimulated mechanism is required for dif- 
ferentiation to occur. Both events can take place 
since rapid translocation of PKC to plasma mem- 
branes [ 151 as well as high affinity PKC binding 
sites and PKC immunoreactivity in isolated nuclei 
[l&18] were demonstrated. 
In HL60 cells, TPA induces a rapid (within 
lo-30 min) translocation of the enzyme from 
cytoplasm to plasma membrane [ 19,201. The pre- 
sent studies investigated possible long-term effects 
of TPA on PKC distribution. Proteases are known 
to transform a significant portion of membrane 
bound PKC to a lower molecular mass, irreversibly 
activated, form [21-231. It is conceivable that this 
truncated PKC (PKM) will dissociate from mem- 
branes and redistribute to other intracellular sites 
more readily than the whole, more hydrophobic, 
molecule. However, present biochemical methods 
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do not distinguish between PKM and other protein 
kinases which makes the study of possible in- 
tracellular redistribution of the former enzyme 
very difficult. To overcome this potential difficul- 
ty, in the present work we used immunostaining 
and immunofluorescence methods to demonstrate 
temporal changes in PKC distribution during the 
entire course of differentiation. 
2. MATERIALS AND METHODS 
2.1. Materials 
TPA was purchased from Sigma; the Vectastain biotin- 
avidin-peroxidase kit was from Vector Laboratories; 
fluorescein-conjugated goat anti-rabbit IgG was from Cooper 
Biomedical; [y-‘*P]ATP was prepared by the method of Post 
and Sen [24]. Polyclonal anti-PKC antisera [25] was kindly pro- 
TPA, 1nM 
Dav 0 
vided by Peggy R. Girard of this laboratory. PKC was purified 
from pig brain as described for the heart enzyme [26]. Human 
promyelocytic cell line HL60 1271 was cultured as described 
WI. 
2.2. Immunocytochemical localization of PKC 
Cells from log phase were diluted into plastic dishes (2 x 
105/ml) incubated with 1 nM TPA for up to 7 days. Suspended 
cells (untreated or treated with TPA for 1 or 7 days) were first 
pelleted using a cytospin (5 min) and fixed. Attached cells 
(treated with TPA for 2, 3 and 5 days) were directly fixed in the 
plastic dishes. Fixation (30 min) was performed with 4% (w/v) 
paraformaldehyde and 0.1% glutaraldehyde in 50 mM Tris- 
HCI (PH 7.5) followed by washing (7.5 min) with 0.2% (w/v) 
Triton X-100. The immunostaining procedure (fig.1) was the 
same as described [18-201. For immunofluorescence visualiza- 
tion of PKC (fig.2), fixed cells were pretreated with polyclonal 
antisera and stained with fluorescein-conjugated goat anti- 
rabbit IgG [18-201. Preimmune serum was used as control 
which exhibited little or no immunoreactivity [18,25]. 
Dav 1 Dav 2 
Day 3 Day 5 Day 7 
Fig. 1. Redistribution of PKC during differentiation of HL60 cells induced by TPA as determined by immunoperoxidase method. The 
cells were incubated with 1 nM TPA for up to 7 days. The cells at days 0 and 1 were in suspension (undifferentiated), at days 2, 3 
and 5 were attached to substratum (differentiating), and at day 7 became detached and were in suspension (differentiated). 
Visualization of PKC was performed by the immunoperoxidase technique (see section 2). Arrow heads indicate the sites of 
immunoreactivity. 
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2.3. Endogenous protein phosphorylation in nuclei from 
control and attached cells 
Nuclei fractions from control and attached (day 2 after TPA 
treatment) cells were prepared as described [29]. Briefly, the 
cells were suspended in homogenization buffer (10 mM Tris- 
HCl, pH 7.5, 2.5 mM MgClz, 1 mM PMSF, 50,~M leupeptin 
and 0.3 M sucrose) and passed through a syringe (27G 518 nee- 
dle) 15-20 times to rupture cells. Homogenates were centrifug- 
ed at 1000 x g for 10 min and the resulting pellets (nuclear 
fraction) were washed twice with the homogenization buffer. 
The pellets were dissolved in homogenization buffer containing 
0.1% Triton X-100 (instead of sucrose), sonicated for 1 min on 
ice and kept for 20 min on ice before use. The incubation 
medium (0.15 ml) for the endogenous protein phosphorylation 
assay contained 50 mM Tris-HCl, pH 7.5, 10 mM MgClz, 
25 ,uM [y-“P]ATP (4800 cpm/pmol), 0.1% Triton X-100, 
0.5 mM PMSF, 25pM leupeptin, 50-6Opg nuclear proteins 
and, if present, 1Opg of phosphatidylserine (PS), 10 FM CaC12, 
100 nM TPA and 0.2 cg purified PKC. Incubations were car- 
ried out in a shaking water bath for 5 min at 30°C. Reactions 
were terminated by adding 1.4 ml ice-cold acetone; samples 
were kept on ice for 15 min, then centrifuged and the pellets 
were solubilized by incubating them for 5 min in a solution con- 
taining 2% sodium dodecyl sulfate, 20% glycerol, 10 mM Tris- 
HCI. pH 7.5 and 1 mM dithiothreitol. Equal amounts of pro- 
teins (40 /cg) were applied onto 10% polyacrylamide gels. Elec- 
trophoresis and detection of phosphoproteins by 
autoradiography were performed as described [7]. 
3. RESULTS 
We have reported [19,20] that TPA 
(lo-200 nM) caused a rapid (within lo-30 min) 
translocation of PKC from cytoplasm to plasma 
membrane in HL60 cells. In the present studies, we 
examined the patterns of PKC redistribution in 
HL60 cells during the entire course of differentia- 
tion induced by a low concentration (1 nM) of 
TPA. At day 0 of TPA treatment (i.e. no treat- 
ment), the PKC immunostaining in the cells was 
largely cytoplasmic, but it became more concen- 
trated around nuclear membrane or perinuclear 
region at day 1 (fig-l). PKC was then associated 
with the nuclear membrane region and, to a lesser 
extent, in plasma membrane at day 2, and was 
TPAJnM - 
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Fig.2. Redistribution of PKC during differentiation of HL60 cells induced by TPA as determined by immunofluorescence technique. 
The treatment and characteristics of the cells were essentially the same as indicated in fig.1. Visualization of PKC was performed using 
the immunofluorescence technique (see section 2). The arrow heads indicate the sites of immunoreactivity. 
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heavily localized in both plasma and nuclear mem- 
branes at day 3. By day 5, most of the im- 
munoreactivity was detected in cytoplasm and 
nuclear membrane although some staining was 
also evident in plasma membrane. Most of the cells 
(about 70%) became attached to substratum 
(characteristic of differentiating cells) during days 
2-5, and immunocytochemical micrographs of 
PKC in these attached cells were shown here. Most 
of the staining was found in the cytoplasm at day 
7, when the cells became fully differentiated and 
detached from the substratum (fig.1). Patterns of 
temporal changes in PKC redistribution during the 
course of differentiation of HL60 cells, similar to 
those shown above in fig.1, were also observed in 
a separate series of experiments using im- 
munofluorescence technique to visualize the en- 
zyme (fig.2). We should note here that in many 
attached cells, treated with TPA for 24-48 h, less 
immunoreactive material seemed to be present 
than in control cells. Fig.2 shows a population of 
cells which contained decreased amount of PKC 
after TPA treatment for 2 days. This 
phenomenon, known as down-regulation of PKC, 
may be due to protease-catalyzed loss of the en- 
zyme which often occurs in response to TPA- 
treatment [21-231. In five experiments, performed 
similarly to that reported in fig.2, we have not 
observed significant down-regulation of the en- 
zyme at later stages of differentiation. 
Because nuclear localization of the PKC im- 
munoreactivity appeared to be the most obvious at 
day 2 of TPA treatment (figs 1 and 2), we chose the 
attached cells at this stage of differentiation to ex- 
amine possible changes in the pattern of nuclear 
protein phosphorylation. It was observed that 
phosphorylation of nuclear proteins from control 
cells was not stimulated by PS/Ca2+/TPA (fig.3, 
lanes 1 and 2), but phosphorylation of several 
other proteins (notably the 98, 85, 80, and 45 kDa 
species) was augmented by PS/Ca2+/TPA in the 
presence of exogenous PKC (fig.3, comparing lane 
4 with lane 3), suggesting a deficiency in nuclear 
PKC in control cells to phosphorylate these pro- 
teins. The nuclei from attached cells (day 2) ex- 
hibited phosphorylation of a similar set of proteins 
shown to be phosphorylated by exogenous PKC in 
the nuclei from control cells (fig.3, comparing lane 
5 with 4); however, several proteins, especially the 
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Fig.3. Protein phosphorylation in the nuclei from 
undifferentiated and differentiating HL60 cells. The nuclei 
from undifferentiated (suspended) cells (lanes l-4) untreated 
with TPA and differentiating (attached) cells 2 days after 
treatment with 1 nM TPA (lanes 5 and 6) were incubated with 
[y-‘*P]ATP in the absence or presence of PS (lO/cg), CaC12 
(10pM) and TPA (100 nM), as indicated. Purified pig brain 
PKC (0.2 cg) was also present in certain incubation mixtures 
(lanes 3 and 4). Detailed procedures for purification of nuclei 
and protein phosphorylation were described in section 2. 
labelled in the attached cells. In addition to the 
above changes, 32P-labelling of several lower 
molecular mass proteins, prominent in the control 
cell nuclei (fig.3, lanes l-4), were undetectable in 
the attached cell nuclei (fig.3, lane 5). Using Hl 
histone as exogenous substrate, we found about 
20-fold more PS/Ca2+/TPA-dependent PKC ac- 
tivity in attached cell nuclei, compared to control 
cell nuclei (not shown). In spite of this, protein 
phosphorylation in attached cell nuclei was not 
stimulated further by PKC activators (fig.3, lane 
6). 
4. DISCUSSION 
To our knowledge this is the first report which 
describes sequential changes in PKC distribution 
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during the entire course of HL60 cell differentia- 
tion. Activation of PKC, the only hitherto 
recognized cellular target of phorbol esters, is 
crucial for the macrophage-type differentiation of 
leukemic cells, induced by TPA [5-111. Although 
this suggests that the observed alterations in PKC 
localization are physiologically important, a causal 
relationship between PKC distribution and HL60 
cell differentiation remains to be proven. 
During the course of this and a previous study 
[20], we observed that 30 min treatment of cells 
with 100 nM TPA (followed by washing of cells) 
was sufficient to induce both PKC translocation 
from cytoplasm to plasma membrane (immediate 
effect) and, within 48 h, cell attachment. At low 
TPA concentration (1 nM), similar effects on both 
cell attachment and PKC translocation were 
observed if cells were treated for at least 4 h. It ap- 
pears that the length of TPA treatment required 
for the induction of cell differentiation strictly cor- 
relates with the time needed for the translocation 
of PKC to plasma membrane, suggesting a rela- 
tionship between the two events. We have only 
limited information about the possible biochemical 
mechanism(s) which may underlie this relation- 
ship. We and others observed significant changes 
in the degradation and synthesis of PC [14,20,28] 
and PS [29], following the early partitioning of 
PKC to plasma membrane in response to TPA. 
Modification of membrane lipid content, and 
thereby the membrane structure, is likely to be a 
precondition for cell attachment. 
Translocation of PKC to the nucleus at day 2 of 
TPA treatment was associated with increased 32P- 
labelling of several proteins. Increased 
phosphorylation of most of these proteins was also 
observed when purified PKC was added to control 
cell nuclei. However, the basal endogenous 
phosphorylation in attached cell nuclei was not 
modified by PS/Ca’+/TPA, suggesting that either 
a truncated PS/Ca2+-independent PKC, or 
another protein kinase (or both) was involved. 
Mapping of phosphorylated sites of these proteins, 
a tool to investigate protein kinase specificity, will 
be required to identify the enzymes involved. 
Phosphorylation of several lower molecular mass 
nuclear proteins, prominent in control cells, were 
undetectable in attached cells. While the reason for 
this phenomenon is not known, one should be 
aware that 32P-labelling of endogenous proteins in 
vitro may not reflect the in vivo situation. It is im- 
portant, therefore, to study phosphorylation of 
nuclear proteins in the intact cells as well. In 
preliminary experiments we prepared the nuclei 
after incubating the cells with 32Pi for 8 h, and 
found that in attached cells the 98, 85 and 80 kDa 
proteins were the most highly labelled, and that the 
lower molecular mass proteins remained poorly 
labelled. 
WhiIe the translocation of PKC to cell nucleus is 
clearly accompanied by an altered protein 
phosphorylation profile, we cannot relate these 
changes to specific biochemical mechanisms in- 
volved in differentiation. It is known, however, 
that various markers of the macrophage-type dif- 
ferentiation, such as superoxide production, non- 
specific esterase activity and the cell surface 
marker Mol appear only 48-72 h after TPA treat- 
ment [30]. Conceivably, the nucleus-associated 
PKC may be involved in the regulation of those 
genes responsible for the production of these dif- 
ferentiation markers. In this respect, it seems 
worth mentioning that apparently more PKC was 
accumulated in nuclei of attached cells than that 
required for endogenous protein phosphorylation, 
suggesting that the enzyme may have other func- 
tions as well. Recent evidence indicates that DNA 
binding proteins contain a common structural 
motif, called ‘zinc finger’, which is involved in bin- 
ding to DNA [3 11. Interestingly, PKC also con- 
tains this putative DNA binding domain, and it has 
been suggested that PKC may directly bind to 
DNA and modulate gene expression [32]. 
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